To Invest in 
GLAXO
0.00 (0.00%)
OverviewFundamentals

 - Share Price & Details

Lowest Today
0
Highest Today
0
Today’s Open
0
Prev. Close
0
52 Week High
0
52 Week Low
0
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
0.00%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
0.00
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

-3.81 %
1 Wk
-0.79 %
1 M
31.48 %
3 M
64.30 %
1 Y
11.11 %
YTD

Traded Volume Movement

Technical Details

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Glaxosmithkline Pharmaceuticals Ltd
₹2,169.85(+0.30/0.01%)
2,169.85+0.3036,758.5764.3057.8323.75
Bliss GVS Pharma Ltd
₹136.10(+6.15/4.73%)
136.10+6.151,424.8467.5720.871.46
Astrazeneca Pharma India Ltd
₹5,567.65(+106.30/1.95%)
5,567.65+106.3013,919.1364.3587.2721.25
Cipla Ltd
₹1,488.55(+18.80/1.28%)
1,488.55+18.80120,179.5054.6536.554.64
Abbott India Ltd
₹28,639.35(+155.90/0.55%)
28,639.35+155.9060,858.6238.2053.1219.58
Amrutanjan Health Care Ltd
₹650.30(-5.00/-0.76%)
650.30-5.001,900.879.8343.187.25

About Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 36758.57 crores. It has reported a sales of Rs. 804.98 crores and a net profit of Rs. 45.49 crores for the quarter ended December 2018. The company management includes Renu S Karnad, D Sundaram,A A Nadkarni,P V Bhide,A N Roy,Subesh Williams,Renu S Karnad,Sunita Maheshwari,Manu Anand,Bhushan Akshikar,J. Chandy (Glaxosmithkline Pharmaceuticals Ltd) among others.
Chairman
Renu S Karnad
Registered office
GSK House,Dr Annie Besant Road Worli,Mumbai,Maharashtra,400030
FAX :91-022-24959494
Background
Incorporation Year1924
Face Value₹10
Market Lot1

Latest News

Tech View: Nifty forms bullish engulfing chart as expiry nears
Nifty on Tuesday ended 64 points higher to form a bullish engulfing pattern on the daily chart after two days of weakness.The near-term uptrend status of Nifty remains positive and bullish chart patterns like higher tops and bottoms are also intact. At the same time, the market is not gaining strength to witness an upside breakout of 22,200-22,300 levels decisively.
27 Feb 2024 | 05:35 PM
Technical View: 22,300 remains crucial for further upmove in Nifty
Nifty 50 rebounded after two days of correction and formed a Bullish Engulfing candlestick pattern on the daily charts on Feb 27, but overall, it has been in a range of 21,950-22,300. Hence, the index needs to break the range on either side to get into a firm direction, experts said, adding if the index decisively manages to surpass 22,300 then 22,500 is the level to watch out on the higher side.
27 Feb 2024 | 05:00 PM
Stock market today: Sensex, Nifty 50 end higher amid volatile trade.
Stock market today: Domestic benchmark equity indices, the Sensex and the Nifty 50, ended Tuesday's session higher amidst a choppy trading session. Investors have been focusing on important US and domestic economic data. The overall trend, according to analysts, is positive, with no negative developments anticipated for domestic markets and expectations that macroeconomic data points.
27 Feb 2024 | 03:54 PM
✅Sensex surges 305 points at the Close; Nifty near 22,200!
✅ Amid positive global cues, benchmark indices closed on a positive note today. 
📢 At 3:30 PM, the Sensex improved by 305.09 points or 0.42% at 73,095.22, and the Nifty was up 76.30 points or 0.34% at 22,198.35.
📊Among sectoral, Nifty IT (⬆️0.72%) turned out to be the best performer while Nifty PSU Bank (⬇️0.56%) saw considerable selling.
27 Feb 2024 | 03:40 PM
Heavyweights help Sensex snap 2-day fall; analysts see Nifty at 22,700!
The Sensex and Nifty bounced back from early losses on February 27 to trade higher in the afternoon, buoyed by gains in heavyweight stocks like TCS, Sun Pharma, Maruti Suzuki, and Hindustan Unilever. Market analysts remain optimistic and expect the Nifty to reach new all-highs in the coming weeks, provided it stays above the 21,990 level. The Sensex and the were trading 0.3 percent higher.
27 Feb 2024 | 03:31 PM

What is the correct way to invest in Glaxosmith?

The correct way to invest in GlaxoSmithKline Pharmaceuticals is to buy the shares of the company through a reputed broker like Motilal Oswal. You can sign up with the broker online and open a dreamt and trading account first. Then, you can place an order to buy the company stock through the broker and invest in the company.

How can I sell Glaxosmith Pharma shares?

To sell GlaxoSmithKline Pharmaceutical shares you must be signed up with a broker like Motilal Oswal. Shares must be held in a demat account to be sold. You also need to have a trading account linked to your demat account. Once you place a sell request with your broker, your shares are sold and the proceeds are credited to your bank account linked with your demat and trading accounts.

What is the ROI of Glaxosmith Pharma shares?

The current year ROI (YTD 17 April 2023) of GlaxoSmithKline Pharmaceutical shares is -3.81%.

Can I buy Glaxosmith Pharma shares now?

You can buy the shares of GlaxoSmithKline Pharmaceuticals now or at any time through a reputed broker like Motilal Oswal. All you require is a demat account linked with a trading account. These two accounts are connected to your bank account and you can easily place a buy order with your broker to buy the shares you want.

What is the trending volume of Glaxosmith Pharma shares?

The trading volume of GlaxoSmithKline Pharmaceutical shares is 53,700 (17 April 2023).
Click here to see your activities